Klinické štúdie Migréna v štáte Florida
12 štúdií pre Migréna hľadá účastníkov v zariadeniach v štáte Florida.
Mestá v štáte Florida
Oficiálny text štúdie (anglicky)
Study of EVO756 in Adults With Migraine
- Clinical Neuroscience Solutions, Inc., Jacksonville
- Apple Medical Research Group, Inc, Miami
- Blessed Healthcase & Research, Miami
- a 4 ďalších
Prebieha náborFáza 2
Vek 18 až 64 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Direct Helpers Research Center, Hialeah
- D&H Tamarac Research Center LLC, Tamarac
- Santos Research Center, CORP, Tampa
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- South Florida Research Phase I-IV, Inc, Miami
- Clinical Associates of Orlando, LLC, Orlando
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- South Florida Research Phase I-IV, Inc, Miami
- Aqualane Clinical Research, Naples
- Clinical Associates of Orlando, LLC, Orlando
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Northwest Florida Clinical Research Group, LLC /ID# 270833, Gulf Breeze
- My Preferred Research /ID# 270312, Miami
- Encore Medical Research - Weston /ID# 271139, Weston
- a 1 ďalších
Prebieha náborFáza 3
Vek 12 až 17 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Memorial Healthcare, Hollywood
- Mayo Clinic Florida, Jacksonville
- Apple Med Research, Miami
- a 1 ďalších
Prebieha náborFáza 4
Vek 18 až 70 · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Encore Medical Research of Boynton Beach LLC /ID# 246833, Boynton Beach
- Gulf Coast Clinical Research Center /ID# 230020, Fort Myers
- AGA Clinical Trials /ID# 230554, Hialeah
- a 9 ďalších
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Neuroscineces Solutions - Orlando, Orlando
- Clinical Neuroscineces Solutions, Orlando
Prebieha náborFáza 2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07646613A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- NW FL Clinical Research Group, LLC, Gulf Breeze
- AGA Clinical Trials - Hialeah - 4980 W 10th Ave, Hialeah
- University of South Florida, Tampa
Prebieha náborFáza 3
Vek 6 až 17 · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT05164172A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Homestead Associates in Research, Inc., Homestead
- Florida Neurology - Lake Mary, Lake Mary
- Flourish Research - Miami, LLC dba Flourish Research, Miami
- a 2 ďalších
Prebieha náborFáza 2
Vek 18 až 70 · Všetky pohlavia · Aktualizované 19. 5. 2026 · NCT06602479Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
- University of Miami, Miller School of Medicine, Miami
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2025 · NCT07159750Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #14, Tampa
Prebieha náborFáza 4
Vek 6 až 11 · Všetky pohlavia · Aktualizované 27. 1. 2025 · NCT04748601Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.